IN2014DN08879A - - Google Patents

Info

Publication number
IN2014DN08879A
IN2014DN08879A IN8879DEN2014A IN2014DN08879A IN 2014DN08879 A IN2014DN08879 A IN 2014DN08879A IN 8879DEN2014 A IN8879DEN2014 A IN 8879DEN2014A IN 2014DN08879 A IN2014DN08879 A IN 2014DN08879A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Fredrik Hübinette
Original Assignee
Nicoccino Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoccino Ab filed Critical Nicoccino Ab
Publication of IN2014DN08879A publication Critical patent/IN2014DN08879A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IN8879DEN2014 2012-03-27 2014-10-22 IN2014DN08879A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615997P 2012-03-27 2012-03-27
EP12161483 2012-03-27
PCT/EP2013/055456 WO2013143891A1 (en) 2012-03-27 2013-03-15 Nicotine formulation

Publications (1)

Publication Number Publication Date
IN2014DN08879A true IN2014DN08879A (ko) 2015-05-22

Family

ID=49258262

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8879DEN2014 IN2014DN08879A (ko) 2012-03-27 2014-10-22

Country Status (21)

Country Link
US (1) US20150096572A1 (ko)
EP (1) EP2830589B1 (ko)
JP (2) JP6412492B2 (ko)
KR (1) KR102038342B1 (ko)
CN (1) CN104411297B (ko)
AU (1) AU2013242200B2 (ko)
BR (1) BR112014023823B1 (ko)
CA (1) CA2868445C (ko)
HK (1) HK1205679A1 (ko)
IN (1) IN2014DN08879A (ko)
MX (1) MX362918B (ko)
MY (1) MY183216A (ko)
NZ (1) NZ626974A (ko)
PL (1) PL2830589T3 (ko)
RS (1) RS58677B1 (ko)
RU (1) RU2625836C2 (ko)
SG (1) SG11201405958RA (ko)
SI (1) SI2830589T1 (ko)
UA (1) UA116440C2 (ko)
WO (1) WO2013143891A1 (ko)
ZA (1) ZA201407677B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170172938A1 (en) * 2014-07-08 2017-06-22 Fertin Pharma A/S Oral delivery system comprising two compartments
EP3558267B1 (en) * 2016-12-20 2023-04-26 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
KR20210107690A (ko) * 2018-12-28 2021-09-01 필립모리스 프로덕츠 에스.에이. 금속염을 포함하는 니코틴 제형
CN113242696B (zh) * 2018-12-31 2023-04-28 菲利普莫里斯生产公司 液体尼古丁制剂
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
GB0508306D0 (en) * 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
EA021392B1 (ru) * 2007-10-11 2015-06-30 Филип Моррис Продактс С.А. Бездымный табачный продукт
CN101896172A (zh) * 2007-12-11 2010-11-24 诺瓦提斯公司 多区膜
EP2405942B1 (en) * 2009-03-13 2017-11-01 Excellent Tech Products i Sverige AB Oral delivery product

Also Published As

Publication number Publication date
MX2014010760A (es) 2015-03-20
KR102038342B1 (ko) 2019-10-30
RU2014143003A (ru) 2016-05-20
EP2830589A1 (en) 2015-02-04
UA116440C2 (uk) 2018-03-26
NZ626974A (en) 2016-09-30
US20150096572A1 (en) 2015-04-09
HK1205679A1 (en) 2015-12-24
SG11201405958RA (en) 2014-10-30
ZA201407677B (en) 2016-05-25
KR20140140021A (ko) 2014-12-08
CA2868445A1 (en) 2013-10-03
WO2013143891A1 (en) 2013-10-03
CN104411297B (zh) 2017-10-24
SI2830589T1 (sl) 2019-06-28
JP2015516948A (ja) 2015-06-18
MX362918B (es) 2019-02-26
JP6412492B2 (ja) 2018-10-24
JP2017226686A (ja) 2017-12-28
BR112014023823A2 (ko) 2017-06-20
PL2830589T3 (pl) 2019-07-31
RU2625836C2 (ru) 2017-07-19
MY183216A (en) 2021-02-18
AU2013242200B2 (en) 2017-03-02
CA2868445C (en) 2020-01-28
RS58677B1 (sr) 2019-06-28
CN104411297A (zh) 2015-03-11
EP2830589B1 (en) 2019-02-13
BR112014023823B1 (pt) 2022-04-26
AU2013242200A1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
BR112014017635A2 (ko)
BR112014018454A2 (ko)
BR112014021487A2 (ko)
BR112014017592A2 (ko)
AR092201A1 (ko)
BR112014022117A2 (ko)
BR112014017607A2 (ko)
BR112013027865A2 (ko)
BR112014020115A2 (ko)
BR112014017634A2 (ko)
BR112014017588A2 (ko)
BR112014013184A8 (ko)
BR112014017630A2 (ko)
BR112014025131A2 (ko)
BR112014017621A2 (ko)
BR112014017622A2 (ko)
BR112014020234A2 (ko)
BR112014018557A2 (ko)
BR112014017631A2 (ko)
BR112014017636A2 (ko)
BR112014017667A2 (ko)
IN2014DN08879A (ko)
BR112014017600A2 (ko)
BR112014017671A2 (ko)
BR112014017596A2 (ko)